Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · IEX Real-Time Price · USD
3.825
+0.025 (0.66%)
Jul 22, 2024, 11:20 AM EDT - Market open
Nuwellis Employees
Nuwellis had 59 employees as of December 31, 2023. The number of employees decreased by 11 or -15.71% compared to the previous year.
Employees
59
Change (1Y)
-11
Growth (1Y)
-15.71%
Revenue / Employee
$150,763
Profits / Employee
-$337,814
Market Cap
2.00M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
NovaBay Pharmaceuticals | 26 |
Windtree Therapeutics | 20 |
Azitra | 10 |
Tivic Health Systems | 9 |
Galmed Pharmaceuticals | 8 |
PainReform | 7 |
180 Life Sciences | 4 |
IMAC Holdings | 4 |
NUWE News
- 5 days ago - Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's - GlobeNewsWire
- 26 days ago - Nuwellis Announces Reverse Stock Split - GlobeNewsWire
- 27 days ago - Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™ - GlobeNewsWire
- 5 weeks ago - DaVita, Nuwellis Extend Pilot Collaboration for Aquadex - Benzinga
- 6 weeks ago - Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase - GlobeNewsWire
- 2 months ago - Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida - GlobeNewsWire
- 2 months ago - Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy - GlobeNewsWire
- 2 months ago - Nuwellis, Inc. Announces First Quarter 2024 Financial Results - GlobeNewsWire